in the urine against time and by assuming that this curve is monoexponential, i.e. a straight line. Bishop and others (1951) , however, indicated that several of their curves and of those obtained by Benedict and others (1949) were not straight when plotted in this way, and this finding was confirmed by S0rensen (1960) . Bishop and others (1951) analysed the curves empirically into two exponential components in order to extrapolate more accurately to zero time. S0rensen (1962) found that, whereas the decline of logarithm isotope concentration in urinary uric acid formed a straight line in the case of a normal subject and of a patient with nontophaceous gout, the line was curved in the case of a patient with chronic tophaceous gout, due perhaps to a continuous process of dissolution and precipitation of uric acid at those areas of tophi in contact with the body fluids; and he proposed a Table I . Twenty investigations using uric acid-2-14C were carried out upon nineteen adult subjects, all hospital inpatients. Five of these (with rheumatoid arthritis, rheumatic fever, convalescent myocardial infarction, ankylosing spondylitis, and essential hypertension) had serum uric acid levels of under 6 0 mg./100 ml.; one, the only female in the series, had essential hypertension with a mean serum uric acid level of 6-6 mg./100 ml. (Case 14); nine had primary gout with no clinical evidence of tophus formation; and four had chronic tophaceous gout. One of the last patients was studied twice, i.e. before and after 9 months' continuous treatment with allopurinol; the findings are given as Cases 10 and 11.
(2) Regimen No patients received uricosuric or antihypertensive therapy during the period of study, although a few were taking low maintenance doses of colchicine. Case 11 was maintained on 600 mg. allopurinol daily throughout the second period of study.
Patients were placed on a low purine, low protein diet (National Institutes of Health, Bethesda, low purine diet: daily purine content approximately 200 mg.) for a preliminary period of not less than 7 days to allow the serum and urinary uric acid levels to reach a steady state, and they were maintained on this diet during the experimental period.
At zero time, the patient voided urine and a base line blood sample was taken. 30 pc. uric acid-2-14C were injected intravenously over a period of 10 minutes. Blood samples were collected at increasing intervals for 11 days. Serum was separated, assayed for uric acid content, and frozen at -20°C. Urine was collected under toluene in six 12-hourly periods followed by eight 24-hourly periods, care being taken to ensure that each patient emptied his bladder at the end of every collection period. Urines were assayed for uric acid content and uric acid-2-14C was extracted.
(3) Isotope Methods (i) Preparation of Intravenous Solution 100 ,c. uric acid-2-14C of specific activity between 0 05 and 0 12 mc./mg. were completely dissolved in 100 ml. isotonic saline by heating. The solution was not allowed to boil. After cooling, 50 ml. were injected into a sealed sterile bottle through an 0 22,u Millipore filter, and the solution was used immediately. After the completion of the injection, aliquots were assayed for uric acid content and standards for urine counting were prepared.
(ii) Preparation of Urine Standards Two standards were prepared by diluting 1I0 ml. of the dose solution to 100 ml. 5 The tubes were placed in a boiling water bath and the uric acid reprecipitated by the dropwise addition of 2 0 N acetic acid. After cooling to room temperature, the precipitated uric acid was collected in a sintered glass funnel and washed with distilled water until the eluate was neutral. The crystals were dried overnight at 80°C. and stored in a desiccator until assayed. Any breakdown products of uric acid in the dose solution which were produced during its preparation were thus eliminated, and the immediate preparation of the standards ensured that no significant breakdown of the uric acid could occur in the dose solution since the time of the injection.
(iii) Preparation of Urine Samples Aliquots of known volume, increasing from 10 to 200 ml. over the period of the investigation, were removed from the 12-and 24-hour collections. 250 mg. inactive uric acid were added to each sample which was then processed by the method of S0rensen (1960) .
(iv) Counting Technique Approximately 25 mg. pure uric acid extracted by this method were weighed into counting vials and, after gentle tapping of the vials to break up any accumulations of uric acid crystals, 20 ml. scintillator gel (Helf, White, and Shelley, 1960) were added by pipette. The vials were shaken vigorously to disperse the suspension evenly, cooled at 4°C., and counted in an automatic liquid scintillation counter. Duplicates were made of at least four samples. Two 25-mg. samples of each standard were prepared in the same way and two background samples of 20 ml. gel were used. A total of 30,000 counts were obtained from the majority of samples, the lowest number of counts being 7,000 when the sample to background ratio was 7:1. The percentage of the injected dose contained in each standard sample and the weight of uric acid originating from urine in each sample was calculated. The percentage of the dose per mg. uric acid in each urine collection was then determined and the results plotted against the midtime collection period.
(v) Assay of Total Serum Activity A standard solution was made by diluting 1-0 ml. of the dose solution to 500 ml. Duplicate serum, standard and background samples were prepared by adding 1 0 ml. serum, standard solution, and inactive serum respectively to 10 ml. scintillator (Bray, 1960) . The samples were shaken and left for 3 hours for the protein precipitate to settle. They were then cooled for 20 minutes at 4°C. and counted in an automatic liquid scintillation counter. 10,000 counts were obtained in samples taken up to 2 days and the total counts decreased to a minimum of 1,000 for the last sample. Internal standards were added and the samples reshaken, allowed to stand for 3 hours and cooled before recounting. The percentage of the dose per mg. uric acid in each serum sample was calculated and the results plotted against the time of sampling.
(4) Chemical Methods
The concentration of uric acid in serum, urine and the solutions prepared for intravenous injection was determined by a slightly modified version of the uricase method of Praetorius (1949) . Glomeruler filtration rate was measured by creatinine clearance (Owen, Iggo, Scandrett, and Stewart, 1954) . Blood urea was determined by a standard Auto-analyzer technique, using diacetyl monoxime.
(5) Data Analysis
The urine data were analysed using the Gilles exponential curve fitting programme (Gilles and Ben Hameid, 1966) to determine the number of exponentials, and the Berman model fitting programme (Berman, Shahn, and Weiss, 1962) to calculate the pool sizes and errors in the parameters. In five of the eleven patients whose data were mathematically better fitted by two exponentials, the Berman programme indicated excessive parameter errors, and for these patients the pool sizes in Table I were therefore calculated using a one compartment model. The analysis procedures used to obtain the results in Table I have been described in detail (Glass, Scott, Gilles, Amot, Holloway, and Ben Hameid, 1968) . Table I shows that all four patients with tophaceous gout (Cases 9, 10, 12, and 16) showed two exponential components. However, two exponential components were also indicated in seven other subjects. Of these, five (Cases 5, 7, 8, 17 , and 18) had gout, four of them (Cases 7, 8, 17 , and 18) with histories ranging from 7 to 20 years and with possible radiological evidence of solid urate deposition. The gout in Case 5, however, was of only 5 months' duration, and two exponential components were also found in Cases 4 and 13-patients with myocardial infarction and hypertension respectively with no evidence of gout. The curves from Cases 16 and 14 are shown in Fig. 1 One subject was studied before (Case 10) and after (Case 11) treatment with the xanthine oxidase inhibitor allopurinol. Before treatment a twocompartment system was indicated but after 9 months of treatment with allopurinol 600 mg. daily (during which a small tophus on one elbow, from which urate crystals had been removed, disappeared) only a single compartment system was shown (Fig.  4) . The serum uric acid fell from 9-9 mg./100 ml. before treatment to 3 4 mg./100 ml. after 9 months' treatment. The pool size fell from 2,471 to 1,031 mg., the 24-hr urinary uric acid from 550 to 172 mg., and the daily turnover rate from 861 to 314 mg. (6) Hypertension Eight patients in this study had a raised blood pressure (Cases 13, 14, 15, 16, 17, 18, 19, and 20) and of these, all but two (Cases 13 and 14) had gout. The relationship between hypertension, impairment of renal function, hyperuricaemia, and gout is incompletely understood, and it is often impossible to trace the sequence of events in individual patients. However, there are some differences between the patients in this group. Cases 13 and 14 did not have gout and the serum uric acid level in Case 13 was normal although rather high in Case 14. Case 15 had been known to be hypertensive since 1947 but did not have his first attack of gout until 1965 at which time he was taking hydrochlorthiazide and his serum uric acid was 9 4 mg./100 ml. In these patients, a raised blood pressure appeared to be the predominant disorder.
Results (1) Exponential Components
In contrast the onset of gout in Cases 16 and 17 was known to precede that of hypertension and there was a family history of gout. In Case 18, there was also a long history of gout with a positive family history and, although his previous blood pressure was unknown, it was only moderately raised at the time of study.
Case The existence of a second pool of exchangeable uric acid in a physiologically different form from that of the first pool is probable in a number of patients studied, most of whom had gout, some with definite clinical tophi. It is reasonable to suppose that such a second pool represents the exchangeable surface of tophaceous deposits or crystalline microtophi. In this respect the two studies (10 and 11) carried out on the same patient before and after 9 months' treatment with allopurinol are of particular interest. At the time of the first study the patient was having severe gouty arthritis and he had a small tophus on one elbow: this was associated with evidence of a second pool. During treatment attacks of acute gout ceased, the tophus disappeared, and the second study indicated the presence of a smaller single pool only. It is conceivable that the two-compartment analysis procedure could provide a method of estimating quantitatively the exchangeable uric acid associated with tophi or microtophi. However, not all the patients with evidence of two pools had gout.
Mean values of exchangeable pool size and daily turnover rates for control subjects with a normal serum uric acid level compare moderately well with those obtained by previous workers, considering the small numbers involved in all the series (Table IV) . The exchangeable pool size was higher in patients with gout or hyperuricaemia, some of whom had turnover rates within the normal range, some in excess.
There is a significant association between the level of serum uric acid and the exchangeable pool size in the range of values shown by the patients studied. This may not be valid in subjects with very high pool sizes and perhaps where there is acute elevation of the serum uric acid, although we have no information on this. There is a similar correlation between urinary uric acid and turnover rate. It has been stressed (S0rensen, 1960 ) that urinary urate cannot be used as a direct measure of total uric acid production, largely on account of extrarenal disposal of urate. The cumulative recovery of urate in the present study was in the region of 60 per cent., a figure much in accordance with those of others, but it is nevertheless clear that urinary uric acid does provide some index of uric acid production. In patients with severe renal failure, urinary excretion will be low despite a high turnover rate; however, Pollard (1968) has shown that in renal failure the serum uric acid level does not tend to rise until the GFR falls to about 20 ml./ min., implying that with lesser degrees of impairment there is little decrease in urinary uric acid excretion. Three subjects in the present study, Cases 16, 17, and 20, had impaired GFRs of 54, 17, and 22 ml./min. respectively, but their urinary uric acid when plotted against turnover rate lay fairly close to the general regression line shown in Fig. 3 .
These correlations are also seen in the other studies to which reference has been made. Thus analysis Benedict and others (1949) 3 of the data of Seegmiller and others (1961) confirms a relation between serum uric acid and exchangeable pool size (r=0 91; P<0001) for non-tophaceous subjects. When tophaceous subjects are included, the relationship is not so close but calculations in this study were based on a monoexponential rate of decline, whereas, as indicated above, it is possible that a double exponential analysis may have been more relevant in these subjects.
Of the eight patients with hypertension (seven of whom were hyperuricaemic) only one showed a clear increase in turnover rate. This was Case 16, in whom there was definite evidence of primary gout with later hypertension. The patients with essential hypertension all had a low turnover rate, which accords with the finding of Breckenridge (1966) who demonstrated that the hyperuricaemia often found in patients with hypertension is due to impaired excretion associated with an abnormality in tubular handling of uric acid.
Calculation of pool size and turnover rates from serum radioactivity showed a clear correlation with values obtained from urine, but the standard error of the estimates were 12 3 and 19 6 per cent. for pool size and turnover rate respectively. This would imply that the application of serum results in a particularly individual is less useful than a study performed by analysis of urine samples.
Summary
The exchangeable pool and turnover rate of uric acid has been determined in nineteen subjects, some with gout and some without, using 14C-labelled uric acid.
In some cases a mathematically significant im- Dans certains cas une amelioration significative et precise dans le nombre d'acces a ete obtenue en d6crivant des courbes d'elimination d'acide urique radio-actif urinaire avec une fonction bi-exponentielle plutot qu'avec une fonction mono-exponentielle. Dans de tels cas, il est suggere que les urates peuvent exister dans un second depot physiologique, peut-etre en relation 'a la surface des tophi ou des micro-tophi cristallins. Un malade montrait une courbe bi-exponentielle avant le traitement et une courbe mono-exponentielle 9 mois apres avoir commenc6 un traitement avec l'allopurinol, impliquant ainsi la disparition d'un second depot.
I1 y a une relation importante entre la dimension des dep6ts et le taux de l'urate serique et entre le taux de d6placement et l'excretion de l'urate urinaire.
L'exactitude avec laquelle la dimension des d6pots et le taux de deplacement peuvent etre estimes par les quantites trouvees dans le serum a aussi ete etudiee. SUMARIO El pool cambiable y el promedio de renovacion del acido urico han sido determinados en diecinueve sujetos, algunos con gota y otros sin ella, usando acido iirico identificado con 14C.
En algunos casos se obtuvo una mejora en el ajuste, matematicamente significativa, describiendo las curvas de eliminacon de acido urico radiactivo urinario con una funci6n biexponencial, mis bien que con una monoexponencial. En tales casos, se sugiere que el urato quiza exista en un segundo pool fisiologico, tal vez en relaci6n a la superficie de tofos o microtofos cristalinos. Un paciente revel6 una curva biexponencial antes del tratamiento y una monoexponencial nueve meses despues de haber comenzado el tratamiento con alopurinol, sugiriendo la desaparicion de un segundo pool.
Existe una relacion significativa entre el tamanlo del pool y el nivel del urato s6rico, y entre el promedio de renovaci6n y la excreci6n de urato por via urinaria. Tambien se investigo la precision con que podria calcularse el tamafiodel pool el promedio de renovaci6n, a partir de las medidas del suero.
